{"id":"https://openalex.org/W2184362486","doi":null,"title":"Clinical Trials of Novel Anticoagulants for Severe Sepsis: A Tale of Three Molecules","display_name":"Clinical Trials of Novel Anticoagulants for Severe Sepsis: A Tale of Three Molecules","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2184362486","mag":"2184362486"},"language":"en","primary_location":{"id":"mag:2184362486","doi":null,"is_oa":false,"landing_page_url":"http://advancesinsepsis.com/pdfs/2308.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080897304","display_name":"Steven P. LaRosa","orcid":"https://orcid.org/0000-0002-0773-2816","observed_orcids":["https://orcid.org/0000-0002-0773-2816"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven P. LaRosa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0773-2816","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5025379878","display_name":"Steven M. Opal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven M. Opal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4501,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.70172931,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/severe-sepsis","display_name":"severe sepsis","score":0.9810000061988831},{"id":"https://openalex.org/keywords/septic-shock","display_name":"septic shock","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anticoagulants","display_name":"anticoagulants","score":0.7749999761581421},{"id":"https://openalex.org/keywords/drotrecogin-alfa","display_name":"drotrecogin alfa","score":0.9070000052452087},{"id":"https://openalex.org/keywords/activated-protein-c","display_name":"activated protein C","score":0.8479999899864197},{"id":"https://openalex.org/keywords/antithrombin-iii","display_name":"antithrombin III","score":0.9850000143051147},{"id":"https://openalex.org/keywords/prowess-trial","display_name":"PROWESS trial","score":0.9459999799728394},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.675000011920929},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.6179999709129333},{"id":"https://openalex.org/keywords/blood-coagulation","display_name":"coagulation","score":0.4659999907016754},{"id":"https://openalex.org/keywords/sepsis-treatment","display_name":"sepsis treatment","score":0.5870000123977661}],"concepts":[{"id":"https://openalex.org/C2778005785","wikidata":"https://www.wikidata.org/wiki/Q412888","display_name":"Drotrecogin alfa","level":5,"score":0.9401564598083496},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7694084644317627},{"id":"https://openalex.org/C2778384902","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Sepsis","level":2,"score":0.7559854984283447},{"id":"https://openalex.org/C2779026020","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombin","level":3,"score":0.7334922552108765},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.7234195470809937},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7085782289505005},{"id":"https://openalex.org/C2777628635","wikidata":"https://www.wikidata.org/wiki/Q1765564","display_name":"Septic shock","level":3,"score":0.6835182905197144},{"id":"https://openalex.org/C2781287897","wikidata":"https://www.wikidata.org/wiki/Q412810","display_name":"Protein C","level":2,"score":0.5782767534255981},{"id":"https://openalex.org/C2994086866","wikidata":"https://www.wikidata.org/wiki/Q183134","display_name":"Severe sepsis","level":4,"score":0.271865576505661},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24740099906921387},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2328311800956726},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22029677033424377},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.11288398504257202}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2184362486","doi":null,"is_oa":false,"landing_page_url":"http://advancesinsepsis.com/pdfs/2308.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W126813756","https://openalex.org/W233151749","https://openalex.org/W1527823783","https://openalex.org/W1591408368","https://openalex.org/W1908907230","https://openalex.org/W1932895848","https://openalex.org/W1966438247","https://openalex.org/W1980233581","https://openalex.org/W1997510499","https://openalex.org/W2010275186","https://openalex.org/W2026106674","https://openalex.org/W2030728917","https://openalex.org/W2035942970","https://openalex.org/W2040245197","https://openalex.org/W2042532113","https://openalex.org/W2046913887","https://openalex.org/W2049020632","https://openalex.org/W2059243076","https://openalex.org/W2070946600","https://openalex.org/W2077834849","https://openalex.org/W2083090431","https://openalex.org/W2085545463","https://openalex.org/W2091677130","https://openalex.org/W2103336162","https://openalex.org/W2112348962","https://openalex.org/W2113481864","https://openalex.org/W2115301416","https://openalex.org/W2117196810","https://openalex.org/W2118902632","https://openalex.org/W2119731680","https://openalex.org/W2138129757","https://openalex.org/W2167808553","https://openalex.org/W2273695375","https://openalex.org/W2322121630","https://openalex.org/W2329073622","https://openalex.org/W2415707997"],"related_works":["https://openalex.org/W128477630","https://openalex.org/W2141979055","https://openalex.org/W2070756776","https://openalex.org/W4241215308","https://openalex.org/W1979012632","https://openalex.org/W2018032641","https://openalex.org/W2003549927","https://openalex.org/W2156371140","https://openalex.org/W2961683273","https://openalex.org/W2036700071"],"abstract_inverted_index":{"Over":[0],"the":[1,15,22,39,59,76,93,96,100,114,130,133,141,152,160],"past":[2],"5":[3],"years,":[4],"three":[5,81],"large":[6],"multinational":[7],"clinical":[8,118],"trials":[9,82],"have":[10,127],"been":[11],"conducted":[12],"to":[13,129],"test":[14],"efficacy":[16,31],"of":[17,24,32,79,95,102,116,132,140,148,155,162],"endogenous":[18],"human":[19,64],"anticoagulants":[20],"in":[21,92,99,113,173,178],"treatment":[23],"severe":[25],"sepsis":[26,158],"and":[27,70,98,105,120,138,143,159,164],"septic":[28],"shock.":[29],"The":[30,73,146],"drotrecogin":[33,134],"alfa":[34,135],"(activated)":[35,136],"was":[36],"demonstrated":[37],"by":[38],"PROWESS":[40],"(Recombinant":[41],"Human":[42],"Activated":[43],"Protein":[44],"C":[45],"Worldwide":[46],"Evaluation":[47],"In":[48],"Severe":[49],"Sepsis)":[50],"trial,":[51],"but":[52],"no":[53],"significant":[54],"benefits":[55],"were":[56],"found":[57],"for":[58,75,151,167],"two":[60],"other":[61],"anticoagulants,":[62],"recombinant":[63],"tissue":[65],"factor":[66],"pathway":[67],"inhibitor":[68],"(rTPFI)":[69],"antithrombin":[71,144],"III.":[72],"explanation":[74],"disparate":[77],"results":[78,150],"these":[80,149],"is":[83],"not":[84],"immediately":[85],"evident.":[86],"However,":[87],"there":[88],"are":[89,109,171],"clear":[90],"differences":[91],"structures":[94],"molecules":[97],"mechanisms":[101],"their":[103],"anticlotting":[104],"antiinflammatory":[106],"actions.":[107],"There":[108],"also":[110],"distinguishing":[111],"characteristics":[112],"performance":[115],"each":[117],"study":[119],"differing":[121],"trial":[122,137],"design":[123,161],"elements":[124],"that":[125],"may":[126],"contributed":[128],"success":[131],"failure":[139],"rTFPI":[142],"trials.":[145],"implications":[147],"practical":[153],"management":[154],"patients":[156],"with":[157],"current":[163],"future":[165],"studies":[166],"novel":[168],"antisepsis":[169],"agents":[170],"discussed":[172],"this":[174],"brief":[175],"review.":[176],"Advances":[177],"Sepsis":[179],"2004;4(1):17\u201023.":[180]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}